A current approach to the management of tuberculosis infection.
Jasmer
R M
RM
Department of Medicine, University of California, San Francisco, USA.
Small
P M
PM
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001500:BCG Vaccine; D004977:Ethambutol / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D007121:Immunocompetence; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008403:Mass Screening; D010349:Patient Compliance; D012293:Rifampin / Q000627:therapeutic use; D012307:Risk Factors; D014374:Tuberculin Test / Q000379:methods; D014376:Tuberculosis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*
D000995:Antitubercular Agents; D001500:BCG Vaccine; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin